Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria

Clinical Infectious Diseases

Volumn 27, Issue SUPPL.1, 1998, Pages

  Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GROWTH; CONFERENCE PAPER; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; IMMUNE DEFICIENCY; INFECTION RISK; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS CEPACIA; STENOTROPHOMONAS MALTOPHILIA; XANTHOMONAS MALTOPHILIA;

EID: 0031879743     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514909     Document Type: Conference Paper

References (13)

1. Hancock REW, Speert DP. Antibiotics for Pseudomonas and related infections. In: Dodge JA, Brock DJH, Widdicome JH, eds. Cystic fibrosis: current topics. New York: John Wiley & Sons Inc., 1996:245-66.
2. Sato K, Nakae T. Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. J Antimicrob Chemother 1991;28:35-45.
3. Monohoshi T, Saito T. β-lactamase and β-lactam antibiotics resistance in Acinetobacter anitratum (syn. A. calcoaceticus). J Antibiot (Tokyo) 1977;30:969-73.
4. Sanders WE, Sanders CC. Inducible β-lactamases: clinical and epidemiologic implications for use of newer cerphalosporins. Rev Infect Dis 1988;10:830-8.
5. Hancock REW, Bellido F. Antibacterial in vitro activity of fourth generation cephalosporins. J Chemother 1995;7 (suppl 5):29-34.
6. Lambert T, Gerbaud G, Bouvet P, Vieu JF, Courvalin P. Dissemination of amikacin resistance gene aph A6 in Acinetobacter sp. Antimicrob Agents Chemother 1990;34:1244-8.
7. Lecso-Bornet M, Pierre J, Sarkis-Karam D, Lubera S, Bergogne-Gerezin E. Susceptibility of Xanthononas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro. Antimicrob Agents Chemother 1992;36:669-71.
8. Muratani T, Yokota E, Nakane T, Inoue E, Misuhashi S. In vitro evaluation of the four β-lactamase inhibitors: BRL42715, clavcelanic acid, sulbactam and aazolactam. J Antimicrob Chemother 1993;32:421-9.
9. Hancock REW, Worobec EA. Outer membrane proteins. In: Montie T, ed. Biotechnology handbook, Pseudomonas. London: Plenum Press, 1996 (in press).
10. Hancock REW, Seihnel R, Martin N. Outer membrane proteins of Pseudomonas. Molec Microbiol 1990;4:1069-75.
11. Hancock REW, Bell A. Antibiotic uptake in Gram-negative bacteria. Eur J Clin Microbiol Infect Dis 1988;7:713-20.
12. Nikaido H, Hancock REW. Outer membrane permeability in Pseudomonas aeruginosa. In: Sokatch J, ed. The bacteria. Vol 10. Orlando, Florida: Academic Press, 1986:145-93.
13. Parr T, Moore RA, Moore L, Hancock REW. Role of porin in intrinsic resistance of Pseudomonas cepacia. Antimicrob Agents Chemother 1987;31:121-3.